Thrombolytic Therapy During ex-vivo Normothermic Machine Perfusion of Human Livers Reduces Peribiliary Vascular Plexus Injury.

MLA

Haque, Omar, et al. “Thrombolytic Therapy During Ex-Vivo Normothermic Machine Perfusion of Human Livers Reduces Peribiliary Vascular Plexus Injury.” Frontiers in Surgery, vol. 8, June 2021, p. 644859. EBSCOhost, https://doi.org/10.3389/fsurg.2021.644859.

APA

Haque, O., Raigani, S., Rosales, I., Carroll, C., Coe, T. M., Baptista, S., Yeh, H., Uygun, K., Delmonico, F. L., & Markmann, J. F. (2021). Thrombolytic Therapy During ex-vivo Normothermic Machine Perfusion of Human Livers Reduces Peribiliary Vascular Plexus Injury. Frontiers in Surgery, 8, 644859. https://doi.org/10.3389/fsurg.2021.644859

Chicago

Haque, Omar, Siavash Raigani, Ivy Rosales, Cailah Carroll, Taylor M Coe, Sofia Baptista, Heidi Yeh, Korkut Uygun, Francis L Delmonico, and James F Markmann. 2021. “Thrombolytic Therapy During Ex-Vivo Normothermic Machine Perfusion of Human Livers Reduces Peribiliary Vascular Plexus Injury.” Frontiers in Surgery 8 (June): 644859. doi:10.3389/fsurg.2021.644859.